27-Oct-2026 10:08:58

ONESOURCE Q2 : CONS NET PROFIT UP 448% AT ₹57.5 CR (YOY), UP 130% (QOQ). STRONG (ON 1ST LOOK)

Revenue up 37.4% at ₹516.2 Cr (YOY), up 15.0% (QOQ). Ebitda up 53.3% at ₹163.3 Cr (YOY), up 32.4% (QOQ); margins 31.6% v 28.3% (YOY), 27.5% (QOQ). Caution: Q2 consolidated exceptional loss of ₹1.77 Cr (Q1 ₹4.30 Cr) on legal charges for subsidiary.

Onesource Specialty Pharma Limited

← Back to feed